Evolus have announced the appointment of two senior roles to their new Australian operations.

Daniel Henry joins as General Manager, Evolus Australia, reporting to Dan Stewart, VP & General Manager, Evolus International. Daniel will focus on the launch of Evolus and on establishing a thriving business in Australia. He brings over 20 years of leadership experience in pharmaceuticals, consumer healthcare, and health & wellbeing sectors across Australia and internationally.

Daniel’s ability to build successful brands and lead innovative commercial strategies will be key to establishing and growing a successful Evolus business in Australia.  His experience in successfully bringing new products to market and accelerating business growth aligns perfectly with Evolus’ commitment to innovation and excellence in the aesthetic industry.

Daniel Henry - GM Evolus Australia

Daniel shared his excitement for the role: “I am thrilled to be joining Evolus at such an exciting time. I look forward to working with the team to bring innovative aesthetic products to Australian customers and make a significant contribution to our journey.”

Maria Estasy joins as Medical Affairs Clinician, reporting to Flavio Azank, Head of Medical Affairs for Evolus International. She will be providing medical support to Australian customers and brings first-hand knowledge as a medical aesthetics nurse injector.

‘I am honoured to be the first associate for Evolus Australia. This speaks volumes about the company’s commitment to healthcare professional customers. I’m looking forward to putting education and clinical support at the heart of the business,’ Maria comments.

Maria Estasy - Medical Affairs Clinician

‘I’m thrilled to welcome Daniel and Maria to Evolus. As we continue to grow rapidly, we need exceptional people to join us on this evolving journey.’ says Dan Stewart, VP & General Manager for Evolus International. ‘The Australian aesthetics market is buoyant and vibrant. We are pleased to be expanding into Australia, underscoring our commitment to global market leadership in medical aesthetics.’

Previous articleHighlights from the Non-Surgical Symposium 2024
Next articleHow to avoid ‘Spock brows’